Results 251 to 260 of about 3,384,149 (326)

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae , 2010 to 2014 [PDF]

, 2016
Laura Mataseje, Kahina Abdesselam, Julie Vachon, Robyn Mitchel, Elizabeth Bryce, Diane Roscoe, David A. Boyd, Joanne Embreé, Kevin Katz, Pamela Kibsey, Andrew E. Simor, Geoffrey Taylor, Nathalie Turgeon, Joanne M. Langley, Denise Gravel, Kanchana Amaratunga, Michael R. Mulvey   +16 more
openalex   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae [PDF]

, 2016
Matthias I. Gröschel, Till F. Omansen, Wiel de Lange, Tjip S. van der Werf, Mariëtte Lokate, Erik Bathoorn, Onno W. Akkerman, Ymkje Stienstra   +7 more
openalex   +1 more source

Identification of Patients at Greatest Risk for Carbapenem Resistance in Patients With Serious Hospital-Onset Infections Due to Enterobacteriaceae Species [PDF]

, 2016
Thomas P. Lodise, Michael Ye, Katelyn R. Keyloun, Qi Zhao, Patrick Gillard   +4 more
openalex   +1 more source

The Prevalence of Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Clostridium difficile Infection in Canadian Hospitals. A Comparison of Survey Results. in 2010, 2012, and 2016. [PDF]

, 2016
Philippe Martin, Victoria Williams, Kathryn Bush, Myrna Dyck, Zahir Hirji, Oscar Larios, Allison McGeer, Christine Moore, Karl Heinz Weiss, Andrew E. Simor   +9 more
openalex   +1 more source

Treatment Outcomes of Third-generation Cephalosporin-susceptible and Resistant <i>Enterobacteriaceae</i> Infection in Dogs and Cats

, 2014
Yui Kimura, Eriko SHIMADA, Tadashi Miyamoto, Shingo Hatoya   +3 more
openalex   +2 more sources

Intravenous‐only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae‐Associated Bacteremic Urinary Tract Infection [PDF]

, 2017
K. Rieger, John A. Bosso, Shawn H. MacVane, Zachary Temple, Amy H. Wahlquist, Nicole Bohm   +5 more
openalex   +1 more source

High drug-pathogen mismatch in the management of invasive carbapenem-resistant Enterobacteriaceae infections at a tertiary hospital in Nigeria. [PDF]

IJID Reg
Adekanmbi O, Popoola O, Fowotade A, Idowu O, Ogunbosi B, Lakoh S, Adebiyi I.   +6 more
europepmc   +1 more source

Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis [PDF]

, 2017
Maged Muhammed, Myrto Eleni Flokas, Marios Detsis, Michail Alevizakos, Eleftherios Mylonakis   +4 more
openalex   +1 more source

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012 [PDF]

, 2017
Tiffany R. Keepers, Marcela Gómez, Chris Celeri, Kevin M. Krause, Donald Biek, Ian A. Critchley   +5 more
openalex   +1 more source